A new player: Affymax wins approval for a new anemia drug
When regulations and quality of life clash
More hot water for author of column on brain death
A New Player
Thinking outside the chair

NEJM article demonstrates shortsightedness of transplant coverage policy
Hgb levels, ESA use drops, but anemia market remains competitive
Fresenius signs licensing agreement in Europe for antipruritic drug,IHS Dialysis claims DaVita monopolizes dialysis care, Former DaVita nurse appeals conviction
MedPAC recommends SGR repeal; study says Frequent dialysis does not markedly improve physical health; study shows differences between dialysis modality choice, initiation
CLICK HERE TO SIGN UP for the Renal Week in Review eNewsletter